Trustmark (TRMK) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Dec, 2025Executive summary
Net income for Q1 2025 was $53.6 million, with diluted EPS of $0.88 and return on average tangible equity of 13.13%.
Loan growth continued, with loans held for investment up 1.2% to $13.24 billion; credit quality remained stable.
Noninterest income rose to $42.6 million, reflecting diversified business lines and expanded fee income.
Noninterest expense declined 0.3% sequentially but increased 3.6% year-over-year to $124.0 million.
Board declared a quarterly dividend of $0.24 per share, payable June 15, 2025.
Financial highlights
Net interest income (FTE) was $154.7 million, with a net interest margin of 3.75%.
Noninterest income increased 4.0% sequentially and 8.2% year-over-year to $42.6 million.
Noninterest expense totaled $124.0 million, down $419,000 sequentially.
Allowance for credit losses represented 1.26% of loans HFI.
Tangible book value per share rose 4.1% sequentially and 26.1% year-over-year to $27.78.
Outlook and guidance
FY 2025 guidance affirmed: loans and deposits (excluding brokered) expected to increase low single digits.
Net interest margin expected in the 3.75%–3.85% range; net interest income and noninterest income to increase mid-to-high single digits.
Noninterest expense expected to rise mid single digits; provision for credit losses to remain stable.
Management expects to maintain robust capital, liquidity, and profitability.
Latest events from Trustmark
- Record earnings, dividend increase, and strong ESG initiatives mark a year of growth and engagement.TRMK
Proxy Filing16 Mar 2026 - Key votes include director elections, executive pay approval, and auditor ratification for 2026.TRMK
Proxy Filing16 Mar 2026 - Record earnings, robust governance, and strong ESG drive 2026 proxy voting recommendations.TRMK
Proxy Filing16 Mar 2026 - Record earnings, higher dividend, and strong capital ratios highlight robust 2025 performance.TRMK
Q4 20253 Feb 2026 - Q2 net income surged on FBBI sale, despite a $182.8M securities loss, with stronger capital.TRMK
Q2 20243 Feb 2026 - Q3 2024 net income rose 51% year-over-year, with higher margins and improved capital ratios.TRMK
Q3 202419 Jan 2026 - Q4 net income up 9.7%, capital and EPS rise on asset sales, with a strong 2025 outlook.TRMK
Q4 20249 Jan 2026 - 2024 featured strong financial gains, enhanced capital returns, and expanded ESG and governance initiatives.TRMK
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor, all board-backed.TRMK
Proxy Filing1 Dec 2025